EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Effects of oral administration of nonselective Trk inhibitor on bladder overactivity in rodent models of prostatic inflammation

Taro Igarashi iD, Shinsuke Mizoguchi, Kanako Matsuoka, Tadanobu Kamijo iD, Shota Kawano, Akira Furuta, Yasuyuki Suzuki, Takahiro Kimura iD, Laura E Pascal, Zhou Wang, Naoki Yoshimura iD

The Prostate · 2024

DOI: 10.1002/pros.24708 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Prostate, 2024. Verfasst von Taro Igarashi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. Hauptthemen laut MEDLINE: Prostatitis, Receptor, trkA, Urinary Bladder, Overactive. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDDK NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Our research focused on the assessment of the impact of systemic inhibition of Trk receptors, which bind to nerve growth factor (NGF) and brain‐derived neurotrophic factor (BDNF), on bladder hypersensitivity in two distinct rodent models of prostatic inflammation (PI).

Methods

Male Sprague‐Dawley rats were divided into three groups ( n = 6 each): the control group (no PI, vehicle administration), the untreated group (PI, vehicle administration), and the treated group (PI, nonselective Trk inhibitor, GNF 5837, administration). PI in rats was induced by a intraprostatic injection of 5% formalin. Posttreatment, we carried out conscious cystometry and a range of histological and molecular analyses. Moreover, the study additionally evaluated the effects of a nonselective Trk inhibitor on bladder overactivity in a mouse model of PI, which was induced by prostate epithelium‐specific conditional deletion of E‐cadherin.

Results

The rat model of PI showed upregulations of NGF and BDNF in both bladder and prostate tissues in association with bladder overactivity and inflammation in the ventral lobes of the prostate. GNF 5837 treatment effectively mitigated these PI‐induced changes, along with reductions in TrkA, TrkB, TrkC, and TRPV1 mRNA expressions in L6‐S1 dorsal root ganglia. Also, in the mouse PI model, GNF 5837 treatment similarly improved bladder overactivity.

Conclusions

The findings of our study suggest that Trk receptor inhibition, which reduced bladder hypersensitivity and inflammatory responses in the prostate, along with a decrease in overexpression of Trk and TRPV1 receptors in sensory pathways, could be an effective treatment strategy for male lower urinary tract symptoms associated with PI and bladder overactivity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProstatitisReceptor, trkAUrinary Bladder, OveractiveAnimalsMaleMiceRatsAdministration, OralBrain-Derived Neurotrophic FactorDisease Models, AnimalInflammationNerve Growth FactorProstateRats, Sprague-DawleyReceptor, trkBUrinary Bladder

Stichwörter der Autor:innen

BDNFNGFTrk receptorsbladder overactivityprostatic inflammation

Substanzen

Brain-Derived Neurotrophic FactorNerve Growth FactorReceptor, trkAReceptor, trkB

Autor:innen und Institutionen

  • Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
  • Department of Pharmacology and Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

ORCID-Profile: Taro Igarashi, Tadanobu Kamijo, Takahiro Kimura, Naoki Yoshimura

Förderung

  • NIDDK NIH HHS
  • NIH HHS

Zitieren

APA

Igarashi, T., Mizoguchi, S., Matsuoka, K., Kamijo, T., Kawano, S., Furuta, A., Suzuki, Y., Kimura, T., Pascal, L. E., Wang, Z., & Yoshimura, N. (2024). Effects of oral administration of nonselective Trk inhibitor on bladder overactivity in rodent models of prostatic inflammation. The Prostate. https://doi.org/10.1002/pros.24708

Vancouver

Igarashi T, Mizoguchi S, Matsuoka K, Kamijo T, Kawano S, Furuta A, et al. Effects of oral administration of nonselective Trk inhibitor on bladder overactivity in rodent models of prostatic inflammation. The Prostate. 2024. doi:10.1002/pros.24708

BibTeX
@article{Igarashi2024,
  author = {Igarashi, Taro and Mizoguchi, Shinsuke and Matsuoka, Kanako and Kamijo, Tadanobu and Kawano, Shota and Furuta, Akira and Suzuki, Yasuyuki and Kimura, Takahiro and Pascal, Laura E and Wang, Zhou and Yoshimura, Naoki},
  title = {Effects of oral administration of nonselective Trk inhibitor on bladder overactivity in rodent models of prostatic inflammation},
  journal = {The Prostate},
  year = {2024},
  doi = {10.1002/pros.24708}
}
Kostenlos starten →